Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.16
+0.44 (3.21%)
At close: Aug 1, 2025, 4:00 PM
14.11
-0.05 (-0.35%)
After-hours: Aug 1, 2025, 7:01 PM EDT

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Takeda Pharmaceutical.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Takeda Pharmaceutical.

Recommendation Trends

RatingDec '22Jan '23Feb '23Mar '23Apr '23May '23
Strong Buy000110
Buy111110
Hold000000
Sell000000
Strong Sell000000
Total111220

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
$30$20
BuyMaintains$30$20+41.24%May 16, 2023
TD Cowen
TD Cowen
Buy
Maintains
$24$30
BuyMaintains$24$30+111.86%Apr 4, 2023
B of A Securities
B of A Securities
Strong Buy
Upgrades
$20
Strong BuyUpgrades$20+41.24%Mar 16, 2023
Cowen & Co.
Cowen & Co.
Buy
Upgrades
$21$24
BuyUpgrades$21$24+69.49%Jul 19, 2022
Cowen & Co.
Cowen & Co.
Hold
Initiates
$20
HoldInitiates$20+37.71%Nov 1, 2019
More Analyst Ratings

Financial Forecast

Revenue This Year
4,603.02B
from 4,581.55B
Increased by 0.47%
Revenue Next Year
4,640.07B
from 4,603.02B
Increased by 0.80%
EPS This Year
148.22
from 67.23
Increased by 120.47%
EPS Next Year
181.79
from 148.22
Increased by 22.65%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingMar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027Mar 31, 2028
Revenue
3,197.81B3,569.01B4,027.48B4,263.76B4,581.55B4,603.02B4,640.07B4,709.93B
Revenue Growth
-2.84%11.61%12.85%5.87%7.45%0.47%0.80%1.51%
EPS
238.96145.87201.9491.1667.23148.22181.79-
EPS Growth
745.88%-38.96%38.44%-54.86%-26.25%120.47%22.65%-
Forward PE
-----14.0811.48-
No. Analysts
-----201716
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
High4.9T5.0T5.2T
Avg4.6T4.6T4.7T
Low4.3T4.3T4.2T

Revenue Growth

Revenue Growth202620272028
High
8.0%
8.6%
11.5%
Avg
0.5%
0.8%
1.5%
Low
-6.6%
-6.8%
-10.5%

EPS Forecast

EPS20262027
High253.03294.72
Avg148.22181.79
Low61.7461.74

EPS Growth

EPS Growth20262027
High
276.4%
98.8%
Avg
120.5%
22.6%
Low
-8.2%
-58.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.